Trials / Unknown
UnknownNCT00173316
Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (planned)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
Detailed description
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
Conditions
Timeline
- Start date
- 2004-08-01
- Completion
- 2005-06-01
- First posted
- 2005-09-15
- Last updated
- 2005-09-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00173316. Inclusion in this directory is not an endorsement.